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Abstract Our relative inability to predict the development of fungal disease and its
clinical outcome raises fundamental questions about its actual pathogenesis. Several
clinical risk factors are described to predispose to fungal disease, particularly in
immunocompromised and severely ill patients. However, these alone do not
entirely explain why, under comparable clinical conditions, only some patients
develop infection. Recent clinical and epidemiological studies have reported an
expanding number of monogenic defects and common polymorphisms associated
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with fungal disease. By directly implicating genetic variation in the functional
regulation of immune mediators and interacting pathways, these studies have
provided critical insights into the human immunobiology of fungal disease. Most of
the common genetic defects reported were described or suggested to impair fungal
recognition by the innate immune system. Here, we review common genetic
variation in pattern recognition receptors and its impact on the immune response
against the two major fungal pathogens Candida albicans and Aspergillus fumi-
gatus. In addition, we discuss potential strategies and opportunities for the clinical
translation of genetic information in the ﬁeld of medical mycology. These
approaches are expected to transﬁgure current clinical practice by unleashing an
unprecedented ability to personalize prophylaxis, therapy and monitoring for fungal
disease.
1 Introduction: Genetic Regulation of the Host-Fungus
Interaction
An increasing number of fungal diseases has been documented over the past two
decades. Although we are constantly exposed to fungi, only a few species can cause
disease in healthy individuals. Opportunistic and otherwise commensal fungi can
instead trigger life-threatening infections in individuals with acquired or
treatment-induced immunodeﬁciencies, such as patients receiving hematopoietic
stem-cell (HSCT) or solid organ (SOT) transplantation, or undergoing anticancer
therapy (Pfaller and Diekema 2010). Many species of fungi are responsible for
invasive infections, although more than 90% of all reported fungal-related deaths
result from infection with species belonging to one of four genera: Candida,
Aspergillus, Cryptococcus and Pneumocystis. These diseases are estimated to affect
more than 2 million people annually and, in some cases, can have mortality rates
that exceed 50% (Brown et al. 2012).
Despite several clinical risk factors typically associated with fungal disease have
been disclosed, the actual mechanisms underlying infection in the human host
remain largely undeﬁned. Like many infectious diseases, fungal infections are
characterized by signiﬁcant interindividual variability in their development, pro-
gression and resolution. While a signiﬁcant contribution to infection might be
credited to virulence traits and the ability of fungi to adapt to the human host, recent
evidence has highlighted a dominant role of heritable factors (Cunha et al. 2013;
Smeekens et al. 2013b; Wojtowicz and Bochud 2014). Our current understanding
of the genetic basis of fungal disease has stemmed from the study of individuals
with rare monogenic defects and from cohort-based studies to identify common
polymorphisms associated with disease (Lionakis and Levitz 2017). In addition,
mouse studies illustrating disparities in susceptibility to experimental infection
between inbred strains have also strengthened the concept of genetic control of
susceptibility to fungal disease (Durrant et al. 2011; Radovanovic et al. 2011).
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Clinical and basic research during the last decade has provided exciting new
insights into the molecular and cellular players involved in the host-fungus inter-
action and antifungal host defense (Netea et al. 2015; van de Veerdonk et al. 2017).
The improved understanding of the genetic mechanisms that regulate host immu-
nity to fungi represents an opportunity for the development of new and more
effective approaches to preventing and treating fungal diseases. In addition, future
studies addressing the genetic architecture of both the host and the fungus and how
it regulates the outcome of their interaction are expected to further support clinical
translation and personalized medical interventions in fungal diseases
(Oliveira-Coelho et al. 2015; Rello et al. 2018). In this review, we explore recent
advances in the immunogenetics of fungal disease and how it modulates innate
immunity to the two major fungal pathogens Candida albicans and Aspergillus
fumigatus. Also discussed is how an improved understanding of the genetic regu-
lation of the host-fungus interaction is expected to reform the clinical management
of fungal disease by paving the way toward precision medical interventions based
on individual host genetics.
2 Pattern Recognition Receptors in Fungal Immunity
Our understanding of innate immunity was revolutionized in the early 90s with the
groundbreaking concept of selective recognition of conserved pathogen-associated
molecular patterns (PAMPs) by germline-encoded pattern recognition receptors
(PRRs) (Takeuchi and Akira 2010). Although there are remarkable differences in
the way different classes of pathogens are perceived by the immune system, the ﬁrst
step in developing a proper innate immune response is widely acknowledged to
require fungal sensing by PRRs (Fig. 1). Owing to its inherent dynamic compo-
sition and variable cellular localization of the different constitutive components
during the interaction with the host, the cell wall is considered the most abundant
source of fungal PAMPs, such as b-1,3-glucans and mannans (Gow and Hube
2012; Latge et al. 2017).
The main families of PRRs include Toll-like receptors (TLRs), C-type lectin
receptors (CLRs), nucleotide-binding oligomerization domain (NOD)-like receptors
(NLRs) and retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) (Netea
et al. 2012). Following the recognition of their cognate ligands, PRRs induce
mechanisms responsible for pathogen clearance, including the secretion of
cytokines and chemokines, phagocytosis and production of reactive oxygen species
(ROS), and orchestrate complex immunoregulatory processes resulting in the
activation of adaptive immunity (Patin et al. 2018). The proﬁciency of fungal
recognition and interaction with the membrane-associated PRRs also relies to a
large extent on the opsonization by different families of soluble pattern recognition
molecules, including collectins, pentraxins, ﬁcolins and components of the com-
plement pathway (Bidula and Schelenz 2016). Of note, studies have highlighted
that these molecules may be exploited as a possible alternative or adjuvants to
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currently available antifungal therapy to increase their efﬁcacy (Lo Giudice et al.
2012; Marra et al. 2014). Besides pathogen-derived molecules, PRRs are also
critically important in responding to products released from damaged host cells
during infection, including nucleic acids, alarmins and metabolic products, col-
lectively termed damage-associated molecular patterns (DAMPs) (Cunha et al.
2012). Regardless of the PRRs or soluble molecules implicated in fungal recog-
nition or opsonization, the activation of antifungal immune responses requires a
coordinated regulation of the function and cellular localization of individual or
cooperating receptors.
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Fig. 1 Overview of PRRs and downstream signaling pathways. PRRs are expressed on the cell
surface or are present in endosomes or the cytosol, where they detect PAMPs and activate
downstream signaling pathways leading to the transcription of cytokines and chemokines, whereas
soluble PRRs bind and opsonize fungi, facilitating their elimination. Upon stimulation, TLRs
activate two disparate pathways that involve myeloid differentiation primary response protein 88
(MYD88) and/or TIR domain-containing adaptor protein inducing IFN-b (TRIF). Crosstalk
between TLR signaling cascades underlies the activation of different cellular processes, including
the transcription of proinflammatory cytokines and chemokines, and type I IFN. On the other hand,
CLRs trigger intracellular signaling pathways typically linked to the activation of the SYK kinase
and CARD9, resulting in a cascade of downstream signaling and cellular activation that regulate
and ﬁne-tune NF-jB activation and cytokine gene expression. The stimulation of NLRs also
regulates NF-jB activation via receptor-interacting protein-like interacting caspase-like apoptosis
regulatory protein kinase (RICK), whereas the NLRP3 and AIM2 inflammasomes process
bioactive proinflammatory cytokines, such as IL-1b
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The role of TLRs in innate immunity was initially proposed following the
observation that Drosophila lacking the hematocyte receptor Toll were extremely
susceptible to infection with fungi and Gram-negative bacteria (Lemaitre et al.
1996). This discovery prompted the identiﬁcation of mammalian TLRs shortly
thereafter (Rock et al. 1998). Similar to other PRRs, TLRs are primarily expressed
in cells of the immune system, including monocytes, neutrophils, basophils, eosi-
nophils and natural killer cells, but also in cells of epithelial, endothelial and stromal
origin (Netea et al. 2012). TLRs are characterized by containing extracellular
domains with leucine-rich repeats that interact directly with PAMPs and cyto-
plasmic domains highly homologous to the sequences in the interleukin (IL)-1 and
IL-18 receptors. After binding to their speciﬁc ligands, TLRs activate signaling
cascades that promote the translocation of transcription factors to the nucleus,
where they induce transcription of genes involved in inflammatory responses and
mechanisms of pathogen clearance (Takeuchi and Akira 2010).
The large family of CLRs includes members such as dectin-1, dectin-2, mannose
receptor, dendritic cell-speciﬁc intercellular adhesion molecule 3-grabbing
non-integrin (DC-SIGN), macrophage inducible C-type lectin (Mincle), macro-
phage C-type lectin (MCL), and the recently identiﬁed MelLec (Brown et al. 2018).
These receptors have carbohydrate recognition domains and bind microbial
polysaccharides and, for this reason, they have been widely implicated in the
activation and regulation of antifungal immune responses (Salazar and Brown
2018). Among CLRs, dectin-1 was the ﬁrst to be identiﬁed and is currently the best
described receptor able to orchestrate the activation of adaptive immune responses
to fungi (Dambuza and Brown 2015). Dectin-1 recognizes b-glucans (Brown and
Gordon 2001) and triggers intracellular signaling pathways that, synergistically and
through cross-regulatory mechanisms, culminate in the activation of nuclear factor
(NF)-jB and cytokine gene expression (Geijtenbeek and Gringhuis 2009).
Although most of the CLR family members have been implicated in antifungal
immunity in one way or another, the fungal ligands for most of them remain
elusive. One exception was recently provided by the identiﬁcation of MelLec as a
speciﬁc receptor for 1,8-dihydroxynaphthalene (DHN)-melanin, a process required
for eliciting protective immunity to A. fumigatus (Stappers et al. 2018). We also
refer the reader to several excellent reviews on the biology of CLRs (Brown et al.
2018; Dambuza and Brown 2015; Salazar and Brown 2018).
Besides the mainly membrane-bound TLRs and CLRs, cytoplasmic PRRs are
activated by pathogens following cell invasion or release of PAMPs into the
cytoplasm. Although the fungal ligands that are recognized by NLRs have not been
identiﬁed, their activation during infection results in the assembly of multimeric
protein complexes named inflammasomes that are primarily responsible for con-
verting inactive pro-IL-1b and pro-IL-18 into bioactive cytokines (van de Veerdonk
et al. 2015). The NLR family pyrin domain containing 3 (NLRP3) and the NLR
family CARD domain containing 4 (NLRC4) inflammasomes were speciﬁcally
credited with a prominent role in the immune response to C. albicans (Borghi et al.
2015; Cheng et al. 2011; Hise et al. 2009; Tomalka et al. 2011). The NLRP3 and
AIM2 inflammasomes were instead shown to form a dual cytoplasmic surveillance
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system that orchestrates protective immune responses against A. fumigatus (Karki
et al. 2015). The contribution of NLRs to the immune response against fungi
nonetheless extends beyond inflammasome formation. Fungal chitin has been
demonstrated to dampen inflammatory responses to C. albicans by inducing the
immunoregulatory cytokine IL-10 via the activation of NOD-containing receptor 2
(NOD2) and TLR9 (Wagener et al. 2014). More recently, NOD1 was found to play
an inhibitory role in the host defense against A. fumigatus by suppressing dectin-1
expression and cytokine responses responsible for optimal fungal killing (Gresnigt
et al. 2017). Taken together, these observations support the existence of highly
dynamic regulatory mechanisms modulated by intracellular fungal recognition with
important consequences to the overall antifungal immune response.
3 Genetic Defects in Pattern Recognition Receptors
and Susceptibility to Fungal Disease
Genetic variation in the genes encoding PRRs can influence susceptibility to dis-
eases caused by a wide range of fungal pathogens (Carvalho et al. 2010). As for
most infectious diseases, genetic defects in the different families of PRRs have been
widely linked with susceptibility to fungal disease (Netea et al. 2012). These
associations highlight the complexity of the host genetic signatures influencing
antifungal host defense. Here, we discuss the most relevant genetic variation in
PRRs, its association with susceptibility to infection by Candida and Aspergillus,
and their functional consequences to the activation of innate immune responses.
3.1 Toll-like Receptors
Following the early description of TLRs, genetic variation in these genes was
proposed to underlie signiﬁcant interindividual differences in susceptibility to
infectious and inflammatory diseases (Netea et al. 2012). Although monogenic or
primary immunodeﬁciencies affecting TLR signaling promote large effect sizes, this
is typically a rare (or very rare) event on the general population that has not been
implicated in the development of fungal disease thus far. However, TLRs are
characterized by remarkable genetic diversity due to strong selective pressures
during their evolution, particularly in the number of single nucleotide polymor-
phisms (SNPs) that lead to substitutions in amino acid residues (Quach et al. 2013).
As such, before the advent of next-generation sequencing and genome-wide
association studies, polymorphisms in TLRs were considered biologically plausible
targets for involvement in susceptibility to infectious diseases, including fungal
infections (Cunha et al. 2010b). Table 1 summarizes relevant genetic variants in
TLRs and their association with susceptibility to infection by Candida and
Aspergillus.
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The TLR4 sequence variants rs4986790 (D299G) and rs4986791 (T399I) con-
stitute an haplotype that has been reported to alter the leucine-rich repeat region of
the receptor and decrease the efﬁciency of ligand recognition (Arbour et al. 2000).
The presence of this haplotype in donors of allogeneic HSCT was associated with
the development of invasive pulmonary aspergillosis (IPA) in the corresponding
patients (Bochud et al. 2008). Although this association was validated in inde-
pendent HSCT cohorts (de Boer et al. 2011; Koldehoff et al. 2013) and in
immunocompetent individuals suffering from chronic aspergillosis (Carvalho et al.
2008), other studies have failed to replicate the ﬁndings (Carvalho et al. 2009;
Fisher et al. 2017; Kesh et al. 2005). The TLR4 haplotype was reported to delay
immune reconstitution after transplant (Koldehoff et al. 2013), and this could
represent a key mechanism justifying its association with IPA in speciﬁc patient
populations. The exact mechanism by which TLR4 variants may influence anti-
fungal immune responses remains however unknown – particularly since no fungal
ligands (or endogenous molecules released during infection) have been identiﬁed to
date – and this may also support the lack of association with other fungal diseases,
including candidemia (Plantinga et al. 2012).
Genetic variation in TLRs other than TLR4 has also been proposed as an
important risk factor for fungal disease. Earlier studies have reported associations of
the polymorphisms rs5743611 (R80T) and rs4833095 (N248S) in TLR1 and
rs5743810 (S249P) in TLR6 with IPA (Kesh et al. 2005), but only TLR6 has been
shown to be required for the human immune response to A. fumigatus (Rubino et al.
2012). TLR1 also appears to be an important repository of genetic variability
Table 1 Genetic variation in TLRs and susceptibility to infection by Candida and Aspergillus
Gene
(s)
SNP(s) Nucleotide
change
Amino
acid
change
Disease(s) References
TLR1 rs5743611 G > C R80T IPA Kesh et al. (2005)
rs4833095 C > T N248S IPA Kesh et al. (2005)
rs5743618 T > G S602I Candidemia Plantinga et al. (2012)
TLR2 rs5743704 C > A P631H RVVC Rosentul et al. (2014)
TLR3 rs3775296 G > T – IPA Carvalho et al. (2012b)
TLR4 rs4986790 A > G D299G IPA and
CPA
Bochud et al. (2008), Carvalho
et al. (2008), de Boer et al. (2011),
Koldehoff et al. (2013)
rs4986791 C > T T399I IPA Bochud et al. (2008), Koldehoff
et al. (2013)
TLR5 rs5744168 C > T R392X IPA Grube et al. (2013)
TLR6 rs5743810 C > T S249P IPA Kesh et al. (2005)
TLR9 rs5743836 C > T – ABPA Carvalho et al. (2008)
The ﬁrst nucleotide (and corresponding amino acid) is the ancestral nucleotide and therefore is
considered the wild-type allele. SNP single nucleotide polymorphism; IPA invasive pulmonary
aspergillosis; RVVC recurrent vulvovaginal candidiasis; CPA chronic pulmonary aspergillosis;
ABPA allergic bronchopulmonary aspergillosis
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increasing susceptibility to candidemia (Plantinga et al. 2012). Although the precise
mechanism(s) whereby TLR1 influences the risk of candidemia remains elusive, the
variant rs5743618 (I602S) has been shown to impair the trafﬁcking of TLR1 to the
cell surface and to result in decreased NF-jB activation and proinflammatory
cytokine responses to TLR1 agonists (Johnson et al. 2007; Wurfel et al. 2008). In
addition, and despite it was not associated with systemic Candida infection
(Plantinga et al. 2012), the rs5743704 (P631H) SNP in TLR2 was implicated in the
development of idiopathic recurrent vulvovaginal candidiasis (RVVC) (Rosentul
et al. 2014). Finally, the variant rs5743836 in the promoter of TLR9 was associated
with the development of allergic bronchopulmonary aspergillosis (ABPA)
(Carvalho et al. 2008), although this study still requires conﬁrmation.
Another interesting example regards TLR5, the receptor for flagellin expressed
by flagellated bacteria (Hayashi et al. 2001), and in which a SNP leading to an early
stop codon (R392X) has been shown to disrupt flagellin recognition (Hawn et al.
2003). In HSCT recipients, the presence of this variant was associated with the
development of IPA (Grube et al. 2013), thereby suggesting a likely important
antifungal function of TLR5 in the non-hematopoietic compartment. However,
functional data is not available, and additional studies are warranted to identify the
so far unsuspected mechanisms (and the ligand) by which TLR5 might influence
susceptibility to IPA. In any case, the fact that R392X presents with a relatively
common frequency without imposing a primary immunodeﬁciency phenotype
suggests a non-essential role for TLR5 in host defense (Wlasiuk et al. 2009).
Despite classically acknowledged as a prototypical receptor for double stranded
RNA (Zhang et al. 2013), TLR3 has been implicated in fungal recognition and
activation of adaptive immune responses. In particular, the regulatory variant
rs3775296 in TLR3 was demonstrated to increase the risk of IPA after HSCT
(Carvalho et al. 2012b). Cross-presenting dendritic cells harboring this variant
displayed an impaired expression of TLR3 and sensing of fungal RNA, which
ultimately resulted in the defective priming of memory CD8(+) T-cell responses to
A. fumigatus. This study was recently supported by evidence demonstrating a
similar association with severe asthma with fungal sensitization (Overton et al.
2017). Although there is no evidence implicating this regulatory variant in sus-
ceptibility to infections by Candida, the non-synonymous SNP rs3775291 (L412F)
in TLR3 was however detected more frequently in patients suffering from chronic
mucocutaneous candidiasis (CMC) (Nahum et al. 2011).
This study represents a critical example of how genetic defects in TLRs (and
other PRRs) may influence adaptive immune responses, in addition to fungal
sensing and innate immunity. Although this has yet to be addressed, there is an
unequivocal need to consider the genetic proﬁle of the patient during diagnostic
approaches based on the measurement of fungal-speciﬁc adaptive immune
responses (Koehler et al. 2018; Potenza et al. 2013). The same applies to
immunotherapeutic strategies focused on the direct or indirect manipulation of
cytokines, since there are many examples of genetic variants that influence cytokine
production and function (Cunha et al. 2017; Johnson et al. 2012). In conclusion, the
success of novel diagnostic and immunotherapeutic approaches for fungal diseases
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will only be possible if guided by personalization based on the interindividual
variability in immune function, particularly for genetic variants with
well-established functional consequences.
3.2 C-Type Lectin Receptors
Given the well-established role of CLRs in the coordination of antifungal immune
responses, their genetic variation has been extensively implicated in susceptibility
to fungal disease (Table 2). The importance of dectin-1 in the recognition of
b-glucan and activation of antifungal immunity has been demonstrated in mouse
studies but also in patients with recurrent fungal infections carrying the early stop
codon polymorphism rs16910526 (Y238X) (Ferwerda et al. 2009; Taylor et al.
2007). This variant results in a truncated form of dectin-1 lacking several amino
acids within the carbohydrate recognition domain, which underlies its decreased
expression at the surface of myeloid cells and a defective production of cytokines,
particularly IL-17, after stimulation with b-glucan or C. albicans (Ferwerda et al.
2009). Following the initial identiﬁcation of Y238X, and given its speciﬁc impact
on the activation of Th17-mediated immunity, it has since been vastly implicated in
mucosal and gastrointestinal fungal colonization (De Luca et al. 2013; Plantinga
et al. 2009; Usluogullari et al. 2014). This functional axis is further demonstrated by
primary immunodeﬁciencies due to rare mutations in STAT3, IL-17RA and IL-17F
that impair Th17 immunity and are associated with CMC and aspergillosis
(Lionakis and Levitz 2018). Because the cellular localization of the different
dectin-1 isoforms regulates the signaling quality of antifungal immunity (Carvalho
et al. 2012c; Fischer et al. 2017), it is also tempting to speculate that this may be
one additional mechanism through which the Y238X variant may contribute to
infection. Of note, another non-synonymous variant in dectin-1 (rs16910527;
I223S) was instead associated with lower levels of interferon (IFN)-c and the risk of
oropharyngeal candidiasis in HIV patients (Plantinga et al. 2010). This suggests that
different pathogenetic mechanisms are likely in place depending on the speciﬁc
structural consequences of genetic variants to dectin-1 function.
Although the clinical phenotype of patients carrying the dectin-1 stop codon is
relatively mild and less severe than that of patients with classic CMC (Puel et al.
2010), the Y238X variant was found to strongly predispose HSCT recipients to the
development of IPA (Chai et al. 2011; Cunha et al. 2010a). Additional variants in
dectin-1, but also dectin-2 and DC-SIGN (CD209), were likewise correlated with
the development of IPA in hematological patients (Fischer et al. 2016; Sainz et al.
2012). Importantly, the genetic deﬁciency of dectin-1 in both the hematopoietic and
non-hematopoietic compartments was disclosed to synergize towards risk of
infection (Cunha et al. 2010a), a ﬁnding that was validated in the largest HSCT
patient cohort at-risk of IPA collected to date (Fisher et al. 2017) and that highlights
the key role of dectin-1 in antifungal immunity across multiple cell types. Among
the many biological processes that are regulated by dectin-1 in response to fungi,
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the production of ROS through the NADPH oxidase system and the activation of
downstream clearance mechanisms is critically important, as reflected by the
extreme susceptibility of patients with chronic granulomatous disease (CGD) to
aspergillosis (Grimm et al. 2013; Kyrmizi et al. 2013). The role of dectin-1 in
immunity to infection may however extend beyond the immediate activation of
antifungal effector mechanisms. For example, recognition of b-glucan has been
demonstrated to confer innate immune memory to infection – a process referred to
as trained immunity (Netea and van der Meer 2017) – by regulating multiple
processes of cellular metabolism (Arts et al. 2016; Bekkering et al. 2018; Cheng
et al. 2014). In the future, it will be critical to assess the extent to which the Y238X
variant predisposes to fungal disease by impairing the induction of “natural” trained
immunity as the result of our constant exposure to fungi.
Mutations in caspase recruitment domain-containing protein 9 (CARD9), the
adaptor molecule that transduces signals from dectin-1 and other CLRs, have been
identiﬁed in patients suffering from mucocutaneous fungal infections (Glocker et al.
2009). Importantly, neutrophils from CARD9-deﬁcient patients were found to
display impaired phagolysosomal killing of unopsonized C. albicans, a phenotype
that was independent of dectin-1 and NADPH oxidase activity, thereby explaining
the variable clinical presentation of fungal infection in patients suffering from
Table 2 Genetic variation in CLRs and susceptibility to infection by Candida and Aspergillus
Gene(s) SNP(s) Nucleotide
change
Amino
acid
change
Disease(s) References
CARD9 rs4077515 G > A S12N ABPA Xu et al. (2018)
CD209 rs4804800 G > A – IPA Sainz et al. (2012)
rs11465384 C > T – IPA Sainz et al. (2012)
rs7248637 A > G – IPA Sainz et al. (2012)
rs7252229 C > G – IPA Sainz et al. (2012)
CLEC1A rs2306894 C > G G26A IPA Stappers et al. (2018)
CLEC7A rs16910526 T > G Y238X Candida
colonization,
RVVC and IPA
Chai et al. (2011), Cunha
et al. (2010a), De Luca
et al. (2013), Fisher et al.
(2017), Plantinga et al.
(2009), Usluogullari et al.
(2014)
rs16910527 A > C I223S Oropharyngeal
candidiasis
Plantinga et al. (2010)
rs7309123 G > C – IPA Fischer et al. (2016),
Sainz et al. (2012)
rs3901533 G > T – IPA Sainz et al. (2012)
The ﬁrst nucleotide (and corresponding amino acid) is the ancestral nucleotide and therefore is
considered the wild-type allele. SNP single nucleotide polymorphism; ABPA allergic
bronchopulmonary aspergillosis; IPA invasive pulmonary aspergillosis; RVVC recurrent
vulvovaginal candidiasis
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dectin-1 and CARD9 deﬁciency and CGD (Gazendam et al. 2014). Human CARD9
deﬁciency was also found to predispose to extrapulmonary aspergillosis with
sparing of the lungs through a mechanism involving the defective accumulation of
neutrophils in infected tissue (Rieber et al. 2016). Of note, the common polymor-
phism rs4077515 (S12N) in CARD9 was recently implicated in the risk of ABPA
(Xu et al. 2018). Mechanistically, work performed in knock-in mice expressing the
mutated form of human CARD9 revealed the remarkable contribution of S12N to
the activation of NF-jB subunit RelB, which in turn promoted the production of
IL-5 in alveolar macrophages and the recruitment of eosinophils to drive Th2
cell-mediated allergic responses. Given the key role of CARD9 in orchestrating the
signals collected from the different CLRs, it will be interesting to assess whether
this or other common genetic variants may impact susceptibility to other forms of
aspergillosis and eventually other fungal infections.
MelLec (encoded by the CLEC1A gene) was recently characterized as the
functional receptor for DHN-melanin from A. fumigatus (Stappers et al. 2018). This
discovery was accompanied by the identiﬁcation of a non-synonymous variant
rs2306894 (G26A) in the cytoplasmic tail of MelLec, suggesting an influence on
intracellular signal transduction rather than on the recognition of DHN-melanin.
Accordingly, the presence of G26A in HSCT donors was found to strongly increase
the risk of IPA in the corresponding recipient as the result of a broad defect in
cytokine production by myeloid cells (Stappers et al. 2018). Although there is still
much to be learned about the mechanisms through which MelLec orchestrates the
immune response against A. fumigatus (Casadevall 2018), these ﬁndings demon-
strate the key role of myeloid-expressed MelLec and its genetic variation to the
human host defense against A. fumigatus.
3.3 NOD-like and RIG-I-like Receptors
Apart from the involvement of NLRs in inflammasome formation, the function of
canonical receptors such as NOD1 and NOD2 in the host defense against fungi
remained until recently poorly studied. Several polymorphisms in NOD1 and
NOD2 have been typically associated with the development of many infectious and
inflammatory diseases, namely Crohn’s disease (Caruso et al. 2014), but not fungal
infections. A recent genetic screening in HSCT patients and corresponding donors
revealed however that the donor rs2066842 (P268S) variant was associated with
protection from IPA (Gresnigt et al. 2018). Mechanistically, mononuclear cells
harboring this variant displayed enhanced phagocytosis and killing capacity
whereas NOD2 activation instead reduced the antifungal potential of these cells.
Further supporting the suppressive effect of NOD2 activation on antifungal effector
functions, NOD2 deﬁciency conferred resistance to experimental aspergillosis in a
mouse model of infection. Altogether, the P268S variants in NOD2 represents one
of the few available examples associated with genetically-determined protection
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from fungal infection and highlights the interesting possibility to block NOD2
signaling as a therapeutic intervention in IPA.
There is an intricate relationship between dectin-1 signaling and inflammasome
formation in response to both C. albicans and A. fumigatus (Cheng et al. 2011;
Said-Sadier et al. 2010). The variable number of tandem repeats (VNTR)
rs74163773 in intron 4 of NLRP3 was reported to be more frequently detected in
women suffering from RVVC (Lev-Sagie et al. 2009), a ﬁnding that was recently
validated in a larger multicenter cohort (Jaeger et al. 2016). Importantly, both
studies demonstrated that the levels of IL-1b were influenced by the number of
intronic repeats carried by the patients, suggesting a regulatory role of this VNTR
on NLRP3 inflammasome activity.
An important role in host defense against C. albicans has also been ascribed to
genetic variants in other cytosolic receptors, namely RLRs. In particular, the mis-
sense variants rs1990760 (A946T) and rs3747517 (H843R) in MDA5 (IFIH1) were
shown to be associated with systemic Candida infection as the result of an altered
cytokine response (Jaeger et al. 2015). Like TLR3, this receptor for viral RNA also
showed unsuspected effects in antifungal immunity, thereby suggesting intracellular
receptors for fungal nucleic acids as novel targets amenable to therapeutic
manipulation. Table 3 illustrates relevant genetic variants in NLRs and RLRs
associated with fungal disease.
3.4 Soluble Pattern Recognition Receptors
In addition to the membrane-bound PRRs discussed in detail above, there are
several soluble molecules that are endowed with the ability to interact with and bind
to microbial polysaccharides without transducing intracellular signals and that
function as opsonins to facilitate phagocytosis (Bidula and Schelenz 2016). Table 4
summarizes relevant genetic variants in soluble PRRs and their association with
susceptibility to fungal disease. The mannose-binding lectin (MBL), a CLR that
Table 3 Genetic variation in NLRs and RLRs and susceptibility to infection by Candida and
Aspergillus
Gene
(s)
SNP(s) Nucleotide
change
Amino acid
change
Disease(s) References
NLRP3 rs74163773 12,9,7,6
VNTR
– RVVC Jaeger et al. (2016),
Lev-Sagie et al. (2009)
NOD2 rs2066842 C > T P268S IPA Gresnigt et al. (2018)
IFIH1 rs3747517 G > A H843R Candidemia Jaeger et al. (2015)
rs1990760 C > T A946T Candidemia Jaeger et al. (2015)
The ﬁrst nucleotide (and corresponding amino acid) is the ancestral nucleotide and therefore is
considered the wild-type allele. SNP single nucleotide polymorphism; VNTR variable number of
tandem repeats; RVVC recurrent vulvovaginal candidiasis; IPA invasive pulmonary aspergillosis
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binds carbohydrate patterns from microorganisms and activates the lectin pathway
of the complement system, stands out as one of the most well-known examples
(Foo et al. 2015). Many studies have established genetic variation to be a major
regulator of the levels and function of MBL in as much as 8% of individuals in the
general population (Sprong and van Deuren 2008). Interestingly, these individuals
do not display any obvious clinical phenotypes, suggesting that MBL deﬁciency
may be, to a large extent, compensated by the redundancy of the humoral innate
immune system, namely by the vast set of molecules that possess similar opsonic
properties. Although not presenting as an outright immunodeﬁciency, the
genetically-determined defect in the function of MBL is acknowledged as an
important risk factor for infection, particularly in immunocompromised hosts.
There are several known combinations of non-synonymous and promoter variants
in the gene encoding MBL, either affecting the expression levels, its functional
activity or both (Carvalho et al. 2010). Several studies have proposed a role for the
rs1800450 (G54D) variant in MBL in the development of RVVC (Babula et al.
2003; Donders et al. 2008; Giraldo et al. 2007; Wojitani et al. 2012), and this was
recently conﬁrmed in a meta-analysis (Nedovic et al. 2014). In addition, the levels
of circulating MBL were found to vary signiﬁcantly during the course of invasive
candidiasis (Damiens et al. 2012), although the extent to which genetic variation
regulated this phenotype was not assessed. The same holds true for IPA, in which
low circulating concentrations of MBL were detected in infected patients
(Lambourne et al. 2009). Although there is no evidence for a contribution of genetic
Table 4 Genetic variation in soluble PRRs and susceptibility to infection by Candida and
Aspergillus
Gene
(s)
SNP(s) Nucleotide
change
Amino
acid
change
Disease(s) References
MBL2 rs5030737 C > T R52C CPA Crosdale et al. (2001), Vaid
et al. (2007)
rs1800450 G > A G54D RVVC Babula et al. (2003), Donders
et al. (2008), Giraldo et al.
(2007), Nedovic et al. (2014),
Wojitani et al. (2012)
PLG rs4252125 A > G D472N IPA Zaas et al. (2008)
PTX3 rs2305619 A > G – IPA Cunha et al. (2014, 2015),
Fisher et al. (2017)
rs3816527 A > C A48D IPA and
mold
infection and
colonization
Cunha et al. (2014, 2015),
Wojtowicz et al. (2015)
rs1840680 G > A – IPA and
CPA
Cunha et al. (2014), He et al.
(2018)
The ﬁrst nucleotide (and corresponding amino acid) is the ancestral nucleotide and therefore is
considered the wild-type allele. SNP single nucleotide polymorphism; CPA chronic pulmonary
aspergillosis; RVVC recurrent vulvovaginal candidiasis; IPA invasive pulmonary aspergillosis
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variants in MBL to invasive disease, the development of chronic pulmonary
aspergillosis was nonetheless linked with the presence of variable MBL alleles at
codon 52 (Crosdale et al. 2001; Vaid et al. 2007). Because most of the studies that
have addressed genetic variation in MBL and risk of fungal disease in the past were
flawed by the limited number of patients analyzed, these associations need to be
revisited in larger and well-characterized cohorts.
Another soluble PRR that has received a great deal of attention in the ﬁeld of
fungal diseases in the past is the long pentraxin-3 (PTX3) (Foo et al. 2015). This
molecule has been shown to bind microbial moieties from a wide range of
microorganisms, including bacteria, viruses, and fungi, particularly A. fumigatus
(Garlanda et al. 2002). Although classic immunodeﬁciencies have not been linked
to PTX3 deﬁciency, common polymorphisms have been disclosed as important risk
factors across different infectious diseases, namely Pseudomonas aeruginosa col-
onization in cystic ﬁbrosis patients (Chiarini et al. 2010) and urinary tract infections
(Jaillon et al. 2014). Remarkably, and according to its nonredundant role in
immunity to A. fumigatus in mouse models of infection (Garlanda et al. 2002),
genetic variation in PTX3 was identiﬁed as a major risk factor for IPA after HSCT
(Cunha et al. 2014). These ﬁndings were validated in a large, independent study
(Fisher et al. 2017) and extended across different clinical settings, including solid
organ transplant recipients (Cunha et al. 2015; Wojtowicz et al. 2015) and patients
with chronic obstructive pulmonary disease (Cunha and Carvalho 2018; He et al.
2018). Collectively, these studies highlight genetic variation in PTX3 as robust
host-derived markers for IPA and lay the foundations for well-designed clinical
trials assessing their validity in the clinical setting.
Earlier studies have suggested binding of galactomannan to PTX3 (Garlanda
et al. 2002). However, deﬁnitive evidence about the actual fungal ligand recognized
by PTX3 is still lacking. This is in line with reports showing binding of PTX3 to the
cell wall of C. albicans (Tierney et al. 2012), although no studies have been
performed to date exploring the contribution of genetic variation in PTX3 to the risk
of infections caused by Candida. Whatever the ligand(s) involved, PTX3 deﬁciency
was found to hamper the normal alveolar expression of the protein and, at a cellular
level, it impaired the antifungal effector mechanisms of neutrophils, namely
phagocytosis and killing (Cunha et al. 2014). The speciﬁc impact of PTX3 deﬁ-
ciency on neutrophil function was corroborated by the loss of the genetic associ-
ation in patients that developed IPA during severe neutropenia. However, additional
mechanisms of antifungal host defense may also be influenced by PTX3 deﬁciency.
The recent demonstration that PTX3 is a critical molecule bridging neutrophil
function and B-cell function, namely class switching, plasmablast expansion and
antibody production, represents one such example (Chorny et al. 2016). In addition,
binding of PTX3 to myeloid differentiation protein 2, an adapter of the TLR4
signaling complex, is critically required for immune protection in experimental
aspergillosis (Bozza et al. 2014). This raises the interesting possibility that the
combined genetic deﬁciency of PTX3 and TLR4 might underlie a higher risk of
IPA than the single defects alone, a hypothesis that requires conﬁrmation.
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The measurement of PTX3 in the bronchoalveolar fluids of mechanically ven-
tilated patients was recently proposed to be endowed with the ability to identify
microbiologically conﬁrmed pneumonia (Mauri et al. 2014). The alveolar con-
centrations of PTX3 are known be determined at the genetic level (Cunha et al.
2014), and, as such, one could expect a further improvement to the diagnostic
performance of PTX3 by knowing in advance the genotypic proﬁle of the patient. In
addition, PTX3 deﬁciency was also shown to influence the levels of alveolar
cytokines in hematological patients suffering from IPA and to impact their ability in
discriminating infection (Gonçalves et al. 2017). More important, reinstating the
normal levels of PTX3 in vitro with the recombinant protein was sufﬁcient to
restore the efﬁcacy of the antifungal effector functions of neutrophils (Cunha et al.
2014). Although data in the clinical setting is so far lacking, these observations
support the potential applicability of PTX3 in novel prophylactic or therapeutic
approaches for IPA in patients at-risk (Carvalho et al. 2012a). As stated above, the
combined use of antifungal therapy and PTX3 treatment has been found to improve
the efﬁcacy of the drug alone in animal models of IPA (Lo Giudice et al. 2012;
Marra et al. 2014).
Another example of a soluble PRR characterized by relevant genetic diversity
regards plasminogen. By mining genetic data obtained from an unbiased screen of
survival data in different strains of mice subjected to experimental aspergillosis, the
non-synonymous variant rs4252125 (D472N) was correlated with the risk of IPA
in patients undergoing HSCT (Zaas et al. 2008). These ﬁndings support the
importance of additional pre-clinical studies testing different models of infection
and evaluating additional immune-related readouts to assist in the discovery of
human genetic variation with an important contribution to the risk of infection.
4 Clinical Translation of Host Genetics in Medical
Mycology
Many studies over the past decade have implicated genetic variation in PRRs in the
risk of developing fungal disease, particularly under predisposing clinical condi-
tions such as those in the hematology setting (Cunha et al. 2011b; van der Velden
et al. 2011). However, a great deal of work is still required to identify the actual
causative alleles and their functional consequences, as well as to precisely pinpoint
the biological mechanisms through which these influence the risk of infection. We
have currently a large amount of genetic links to susceptibility to fungal disease at
our disposal; however, clinical data supporting the translation of these critical
insights into improved patient outcomes has been practically inexistent (Cunha
et al. 2011a). This can be largely attributed to the relatively small effect size of the
identiﬁed variants (since many carriers will not develop infection), which may
negatively influence the discriminatory ability of the genetic proﬁle to inform
clinical decision-making. Although this limitation will hardly be countered soon
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and the use of genetic information to predict the risk of fungal disease is unlikely to
alter clinical practice in the near future, the predictive performance of the genetic
information may beneﬁt from advanced genetic screening strategies and mathe-
matical models. The integration of host and pathogen genetic data into stratiﬁcation
models that also consider the clinical characteristics of the patients are expected to
improve our current ability to predict risk and progression of disease, including the
response to treatment and its duration, and adverse events. A ﬁrst, modest step
toward this goal was recently taken in a study that demonstrated that the concerted
analysis of selected genetic and clinical factors into a predictive model could be
used to guide preemptive therapy in hematological patients (White et al. 2018).
Although genetic data in the clinical setting has historically been investigated
with the goal to develop risk stratiﬁcation and diagnostic strategies, recent studies
illustrating how genetic variation regulates processes of host immunity raises the
exciting possibility that it may also be exploited to guide immunotherapy. Most of
the clinical trials performed to date have failed to account for the signiﬁcant impact
that genetic variation may pose on subgroups of individuals, and this may partly
explain the disappointing outcomes of trials involving anti-inflammatory agents for
the treatment of sepsis (Cohen et al. 2015). There is therefore an urgent need to
identify and characterize relevant genetic variation in the stratiﬁcation of patients
enrolled in clinical trials of immunomodulatory agents (Rello et al. 2018).
The application of next-generation sequencing and systems biology approaches
provide a powerful tool to identify essential genes and pathways in the host-fungus
interaction at a level of complexity that was not possible beforehand (Dix et al.
2016). Although in the ﬁeld of fungal diseases, genetic association studies at the
genome-wide level are scarce, a few examples exist which have enabled the
identiﬁcation of novel players controlling susceptibility to infection (Kumar et al.
2014; Smeekens et al. 2013a). For example, the integration of transcriptional data
and functional genomics revealed an unanticipated role of type I IFN in the host
defense against Candida (Smeekens et al. 2013a). Polymorphisms in type I IFN
genes were found to modulate cytokine production and to drive a skew from a Th17
to a Th1 type of response, thereby predisposing to candidemia in critically ill
patients. More recently, other functional genomics approaches combining whole
genome information and immunological screenings have also provided invaluable
evidence about the genetic regulation of cytokine production in humans in response
to different stimuli, including fungi (Li et al. 2016a, b). By correlating genome-wide
SNP genotypes with cytokine abundance in response to fungal stimulation, several
cytokine quantitative trait loci (QTL), i.e., genetic variants that control cytokine
production, were identiﬁed (Li et al. 2016a). Among them, a cytokine QTL at the
NAA35/GOLM1 locus markedly influenced the levels of IL-6 produced and was
associated with susceptibility to candidemia. Altogether, these studies support the
need to consider the genetic contribution to immune phenotypic variation (e.g.,
cytokine production and immune cell function) to generate accurate maps of the
human genomic architecture regulating susceptibility to fungal disease.
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5 Conclusions
Our current understanding of the immunobiology of human fungal diseases has
derived largely from studies addressing polygenic susceptibility. These studies have
not only revealed the individual contribution of genetic variants but have also
highlighted the complex interactions between adding effects of variants with small
or modest effect sizes to the immune response. The current state-of-the-art is
however not adequate for the needs of clinicians since it does not allow the accurate
prediction of which individuals might develop fungal disease or that may beneﬁt the
most from intensive diagnostic surveillance or alternative prophylaxis and treatment
strategies. Clinical translation of patient genetics will beneﬁt from the concerted
action of clinicians and researchers into the establishment of larger and
well-characterized patient cohorts, as well as comprehensive functional testing to
identify the biological mechanisms of association with infection. By unraveling
molecules and pathways whose expression or function may be regulated at the
genetic level may allow the possibility to target them with personalized
immunotherapeutics aimed at restoring lacking or defective immune components
(Cunha and Carvalho 2012). In conclusion, an improved understanding of how
speciﬁc genetic signatures regulate susceptibility to fungal disease may revolu-
tionize the ﬁeld of medical mycology, opening new horizons and laying the
foundations for personalized medical interventions based on individual genomics in
patients who are at risk.
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